Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841

Journal of Clinical Oncology

Volumn 30, Issue 3, 2012, Pages 263-267

  Franko, Jan ^a   Shi, Qian ^b   Goldman, Charles D ^a   Pockaj, Barbara A ^c   Nelson, Garth D ^b   Goldberg, Richard M ^d   Pitot, Henry C ^b   Grothey, Axel ^b   Alberts, Steven R ^b   Sargent, Daniel J ^b  

^a MERCY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEAL CARCINOMATOSIS COLORECTAL CANCER; PHASE 3 CLINICAL TRIAL; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC THERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84856004661     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.1039     Document Type: Article

References (23)

1. Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004 (Pubitemid 41095110)
2. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004 (Pubitemid 38702844)
3. Kim GP, Sargent DJ, Mahoney MR, et al: Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841. J Clin Oncol 27:2848-2854, 2009
4. Nordlinger B, Sorbye H, Glimelius B, et al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 371:1007-1016, 2008 (Pubitemid 351392040)
5. Abdalla EK, Vauthey JN, Ellis LM, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825, 2004
6. Pawlik TM, Scoggins CR, Zorzi D, et al: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-722, 2005
7. Yedibela S, Klein P, Feuchter K, et al: Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol 13:1538-1544, 2006 (Pubitemid 44749667)
8. Okumura S, Kondo H, Tsuboi M, et al: Pulmonary resection for metastatic colorectal cancer: Experiences with 159 patients. J Thorac Cardiovasc Surg 112:867-874, 1996 (Pubitemid 26339257)
9. Verwaal VJ, Bruin S, Boot H, et al: 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426-2432, 2008
10. Elias D, Lefevre JH, Chevalier J, et al: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681-685, 2009
11. Franko J, Ibrahim Z, Gusani NJ, et al: Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 116:3756-3762, 2010
12. Chu DZ, Lang NP, Thompson C, et al: Peritoneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors. Cancer 63:364-367, 1989 (Pubitemid 19035034)
13. Jayne DG, Fook S, Loi C, et al: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545-1550, 2002 (Pubitemid 35404323)
14. Koppe MJ, Boerman OC, Oyen WJ, et al: Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 243:212-222, 2006 (Pubitemid 43185440)
15. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363, 2000 (Pubitemid 30051820)
16. Blair SL, Chu DZ, Schwarz RE: Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 8:632-637, 2001 (Pubitemid 32847927)
17. Helyer LK, Law CH, Butler M, et al: Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Oncol 14:1264-1271, 2007 (Pubitemid 46536827)
18. Verwaal VJ, van Ruth S, de Bree E, et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743, 2003 (Pubitemid 46606227)
19. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124-132, 1995
20. Folprecht G, Köhne C-H, Lutz M: Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer, in Ceelen WP (ed): Peritoneal Carcinomatosis: A Multidisciplinary Approach - Cancer Treatment and Research. New York, NY, Springer, 2007, pp 425-440
21. Glehen O, Kwiatkowski F, Sugarbaker PH, et al: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 22:3284-3292, 2004 (Pubitemid 41103684)
22. Shen P, Thai K, Stewart JH, et al: Peritoneal surface disease from colorectal cancer: Comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol 15:3422-3432, 2008
23. Dy GK, Hobday TJ, Nelson G, et al: Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: A North Central Cancer Treatment Group review of 3811 patients, n0144. Clin Colorectal Cancer 8:88-93, 2009